'Game-changer' GLP-1s could fix America's obesity crisis—but 2 inequalities stand in the way

For roughly 40% of American adults living with obesity, the medical playbook has barely changed in decades: Eat less, move more, and if that fails, wait until the disease progresses far enough to justify surgery. GLP-1 drugs like Ozempic, Wegovy, and Zepbound have broken that script—but according to Robin Wenzel, head of Wells Fargo Industry Insights, the drugs are exposing a harder problem than obesity itself: who can afford to wait for them to work.

Could AIs become conscious?

MOST PEOPLE believe humans are different. The reason is that Homo sapiens has evolved to be conscious. Many animals feel pain and pleasure; some appear to be self-aware. But the human mind’s unique potential to exhibit a sense of self marks out every member of the species for special treatment.

The new head of America's top children's hospital sees 'the dawn of a new era' for kid cancer treatment

St. Jude Children’s Research Hospital named Dr. Charles W. M. Roberts its new president and chief executive officer Tuesday, replacing Dr. James R. Downing, who led the nonprofit for 12 years.

Moderna's and Merck's personalized mRNA vaccine shows real promise against deadly skin cancer melanoma in late stage trial and sends stocks soaring

Moderna and Merck said Wednesday their personalized mRNA cancer vaccine met its main goals in a Phase 3 trial targeting melanoma, marking the first time a therapy of its kind has succeeded at that stage of testing. The news sent Moderna’s stock up more than 100% and lifted Merck shares as well, as investors bet on a new era for a company long defined by its Covid-19 vaccine.

'Often flying blind': Up to $246 million of taxpayer-funded CDC programs are largely unstaffed

The Centers for Disease Control and Prevention still has an Alzheimer’s disease program. Congress appropriated $41 million to it this year. There’s just no one staffing it.

Moderna shares double on skin cancer vaccine success

Drugmaker’s melanoma shot developed with Merck delivers positive outcome in late-stage trial

mRNA cancer vaccine succeeded in Phase 3 melanoma trial, Moderna and Merck say

The vaccine reportedly thwarted the cancer’s return and spread.

I quit Coca-Cola. What should I drink now?

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.

Doctors argue their role in the age of AI

Humans must remain in the loop, the AMA maintains.

Obsessed with . . . sweetcorn

Bridging the divide between sweet and savoury, the sunshine vegetable is everywhere this summer, from cornbreads to ice cream and even cocktails

Sabotage: Experts, lawmakers blast RFK Jr. for destroying healthcare research

US healthcare is broken. Under RFK Jr., the research agency working to fix it is, too.

Best Labor Day Treadmill Sales of 2026: Top Treadmill Deals

When balancing a busy schedule, sneaking out of the house for a run isn’t always feasible. But if you want to squeeze in a quick run between meetings or while your child is napping, a treadmill is a great piece of equipment to have in your home. Labor Day is the ideal time to finally purchase that treadmill you’ve been wanting—chances are, you’ll find it at a great discount. Shop our team’s favorite Labor Day treadmill sales.